Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
36.36
+0.08 (0.22%)
At close: Jul 24, 2026, 4:00 PM EDT
37.36
+1.00 (2.75%)
After-hours: Jul 24, 2026, 7:34 PM EDT

Agios Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
66.0554.0336.526.8214.24-
Revenue Growth
78.34%48.03%36.07%88.36%--
Gross Profit
59.4747.6832.3323.9412.54-
Operating Income
-475.53-472.13-425.74-391.49-389.05-378.42
Net Income
-422.6-412.78673.73-352.09-231.81,605
Earnings Per Share
-7.25-7.1211.64-6.33-4.2326.55
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
737.04854.43893.71776.93783.121,020
Total Debt
35.7540.2156.997285.6697.09
Net Cash (Debt)
701.29814.22836.72704.93697.46922.92
Net Cash Growth
-16.56%-2.69%18.70%1.07%-24.43%97.32%
Net Cash Per Share
12.0314.0514.4512.6712.7315.27

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-380.41-372.98-389.84-296.06-309.48-407.32
Capital Expenditures
-4.32-4.32-1.69-1-4.88-
Free Cash Flow
-384.73-377.29-391.53-297.06-314.36-407.32
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
90.04%88.26%88.59%89.26%88.03%-
Operating Margin
-719.97%-873.87%-1166.47%-1459.52%-2732.07%-
Pretax Margin
-641.38%-765.89%1967.15%-1312.63%-1627.82%-
Profit Margin
-639.84%-764.01%1845.92%-1312.63%-1627.82%-
FCF Margin
-582.50%-698.33%-1072.73%-1107.49%-2207.58%-

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--2.82--1.24
Forward PE
-7.847.84---
PS Ratio
32.7429.4551.4646.45108.53-